Kim et al. [61] showed that complement component 8 gamma (C8G) reduces neuroinflammation and blood–brain barrier permeability and inhibits glial hyperactivation and cognitive decline in acute and chronic animal models of Alzheimer’s disease by antagonizing S1PR2 activation. Here, S1PR2 is linked to Mental deterioration.